[Prognostication in hematological malignancies: overview]. 2007

Masami Hirano
Department of Clinical Pharmacotherapeutics, Meijo University Faculty of Pharmacy.

UI MeSH Term Description Entries
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019337 Hematologic Neoplasms Neoplasms located in the blood and blood-forming tissue (the bone marrow and lymphatic tissue). The commonest forms are the various types of LEUKEMIA, of LYMPHOMA, and of the progressive, life-threatening forms of the MYELODYSPLASTIC SYNDROMES. Blood Cancer,Hematologic Malignancies,Hematopoietic Neoplasms,Hematologic Malignancy,Hematological Malignancies,Hematological Neoplasms,Hematopoietic Malignancies,Malignancies, Hematologic,Malignancy, Hematologic,Neoplasms, Hematologic,Neoplasms, Hematopoietic,Blood Cancers,Cancer, Blood,Hematologic Neoplasm,Hematological Malignancy,Hematological Neoplasm,Hematopoietic Malignancy,Hematopoietic Neoplasm,Malignancy, Hematological,Malignancy, Hematopoietic,Neoplasm, Hematologic,Neoplasm, Hematological,Neoplasm, Hematopoietic

Related Publications

Masami Hirano
January 2007, Nihon rinsho. Japanese journal of clinical medicine,
Masami Hirano
November 2011, Current cancer drug targets,
Masami Hirano
July 2019, International journal of hematology,
Masami Hirano
July 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Masami Hirano
March 2007, Gan to kagaku ryoho. Cancer & chemotherapy,
Masami Hirano
January 2007, Methods in molecular biology (Clifton, N.J.),
Copied contents to your clipboard!